In light of ALLHAT and ASCOT: Are there benefits of statins as add-on treatment in hypertensives?

Author： KJELDSEN SVERRE E.   HEDNER THOMAS   HIMMELMANN ANDERS  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.12, Iss.3, 2003-01, pp. : 132-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients

By Bozek Andrzej   Warkocka-Szoltysek Barbara   Filipowska-Gronska Agata   Jarzab Jerzy  

Journal of Asthma, Vol. 49, Iss. 5, 2012-06 ,pp. : 530-534

Informa Healthcare

Access to resources Recommend Favorite

Synergistic Effects of Calcium Antagonists and Statins on Endothelial Function: A New Lesson from the ASCOT Trial

By Taddei Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 14, Iss. 3, 2007-01 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite

A subgroup analysis of the MONICA study: A 12-month, open-label study of add-on montelukast treatment in asthma patients

By Virchow J. Christian   Mehta Anish   Ljungblad Li   Mitfessel Harald  

Journal of Asthma, Vol. 47, Iss. 9, 2010-11 ,pp. : 986-993

Informa Healthcare

Access to resources Recommend Favorite

Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives

By Hjelstuen Anne   Anderssen Sigmund   Holme Ingar   Seljeflot Ingebjørg   Klemsdal Tor Ole  

Scandinavian Cardiovascular Journal, Vol. 41, Iss. 5, 2007-01 ,pp. : 313-320

Informa Healthcare

Access to resources Recommend Favorite

ALLHAT: a critical assessment

By Sjöholm Åke  

Blood Pressure, Vol. 13, Iss. 2, 2004-04 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite